Media, Video 27 Jun 2021 Video | Stockhead Investor Presentation – June 2021 Orthocell CEO and Managing Director Paul Anderson spoke with Oriel Morrison as part of Stockhead V-Con Biotechs. Orthocell
Media, Video 22 Jun 2021 Video | Ticker News Interview – June 2021 Orthocell CEO and Managing Director, Paul Anderson, spoke with Ticker News about the positive findings from our CelGro™ clinical study. Orthocell
Media, Video 22 Jun 2021 Video | Proactive Investors – June 2021 Orthocell CEO and Managing Director Paul Anderson discusses with Proactive positive nerve regeneration results one year on from a study… Orthocell
Video 21 Jun 2021 Orthocell (ASX:OCC) demonstrates potential to return function to paralysed limbs Orthocell has been featured in The Market Herald, following the announcement of clinical data from the CelGro nerve regeneration trial… Orthocell
Media 16 Jun 2021 Orthocell (ASX:OCC) secures Chinese and NZ patents Orthocell has been featured in The Market Herald, following our announcement of patents granted in China and New Zealand for… Orthocell
